Back to search

Article

Sustained impact of 10-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in Kenya, 2011-2022

2024-04-22

Abstract excerpt

<h4>Background</h4> There are only a few long-term PCV impact assessments in sub-Saharan Africa, and these have been confined to settings using a 13-valent PCV. A 10-valent PCV was introduced in Kenya in 2011 with catchup vaccination among children aged <5 years in Kilifi. We evaluated the impact of PCV10 introduction in Kilifi through 2022. <h4>Methods</h4> Surveillance for IPD among residents of the Kilifi Healt...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
5b6cbcca-6d7b-5b3d-8537-3604a45462f5
DOI
10.1101/2024.04.22.24306163
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Sustained impact of 10-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in Kenya, 2011-2022DOI 10.1101/2024.04.22.24306163
Serotype-specific pneumococcal invasiveness: a global meta-analysis of paired estimates of disease incidence and carriage prevalenceSemantic proximity
The landscape of paediatric infectious disease exposure in a rural sub-Saharan Africa setting in Kilifi, Kenya: longitudinal serological analysis over two decades and priorities for future vaccine developmentSemantic proximity
Impact of the National Vaccination Strategy on the Prevalence of <em>Streptococcus pneumoniae </em>and Its Serotypes Among Clinically Healthy Children Under Six Years of Age During and After the COVID-19 PandemicSemantic proximity
The impact of vaccine products, schedules and geographic regions on immunogenicity of pneumococcal vaccines in children under 2 years old: a systematic review and meta-analysisSemantic proximity
Serotype epidemiology and case-fatality risk of invasive pneumococcal disease: a nationwide population study from Switzerland, 2012–2022Semantic proximity
Epidemiological impact and cost-effectiveness analysis of COVID-19 vaccination in KenyaSemantic proximity
Pre-Vaccination Nasopharyngeal Pneumococcal Carriage in a Nigerian Population: Epidemiology and Population BiologySemantic proximity
Estimating pneumococcal carriage dynamics in adults living with HIV in a mature infant pneumococcal conjugate vaccine program in Malawi, a modelling studySemantic proximity
Incidence rates, emerging serotypes and genotypes, and antimicrobial susceptibility of pneumococcal disease in Taiwan: A multi-center clinical microbiological study after PCV13 implementation.Semantic proximity
Early signals of vaccine driven perturbation seen in pneumococcal carriage population genomic dataSemantic proximity
Characterization of Emerging Serotype 19A Pneumococcal Strains in Invasive Disease and Carriage, BelgiumSemantic proximity
Pneumococcal lineages associated with serotype replacement and antibiotic resistance in childhood invasive pneumococcal disease in the post-PCV13 era: an international whole-genome sequencing studySemantic proximity
Select a neighboring publication to make it the new centre.